PDCD1 and head and neck squamous cell carcinoma: To determine the underlying mechanism accounting for the response to anti-PD-1/PD-L1 therapy in HPV-associated HNSCC patients, we carried out gene set enrichment analysis (GSEA) to identify pathways enriched in specific HPV status.